Print page
Email page
Download PDF
« Previous Release | Next Release »
COLUMBIA, Md., Nov 06, 2008 (BUSINESS WIRE) -- Celsion Corporation (NASDAQ: CLSN), a biotechnology drug development company that is leveraging its Heat Sensitive Liposomal Technology platform to encapsulate and deliver high concentrations of proven chemotherapeutics, today announced that it would hold a conference call to discuss third quarter results at 11:00 a.m. Eastern Time on Thursday, November 13, 2008. To participate in the call, interested parties may dial 877-604-2080 (U.S./Canada) or 706-902-1383 (International) and use Conference ID: #72753429 to register ten minutes before the call is scheduled to begin. The call will also be broadcast live on the Internet at http://www.celsion.com.
The call will be archived for replay on November 13, 2008 at 2:00 P.M. and will remain available until Thursday, November 20, 2008. The replay can be accessed at 800-642-1687 or 706-645-9291 using Conference ID: #72753429. The call will also be available on the Company's website, http://www.celsion.com for 30 days after 2:00 p.m. on Thursday, November 13, 2008.
The company also announced that it will be presenting at the Rodman & Renshaw Annual Global Investment Conference in New York City on November 11, 2008. The presentation is scheduled to begin at 4:30 p.m. Eastern Time in the Holmes I Room of the New York Palace Hotel. A 30-day archive of the presentation may be accessed at http://www.celsion.com.
About Celsion: Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat-activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, Cleveland Clinic, North Shore Long Island Jewish Health System.
For more information on Celsion, visit our website: http://www.celsion.com.
SOURCE: Celsion Corporation
FD Geoff Grande, CFA, 617-747-1721 geoff.grande@fd.com
Copyright Business Wire 2008
News Provided by COMTEX
